Introduction {#s1}
============

Recently, the concept of adherence to medication has gained increasing attention ([@B36]; [@B52]) and has become an important public health issue ([@B3]; [@B25]). The WHO recommends the use of the dispensed proportion of prescribed drugs, the primary adherence to medication, as a basic indicator of health care operation ([@B83]). Indeed, medication adherence is considered the cornerstone in the management, control, and prevention of loss of the desired therapeutic outcome, disease progression, and complications ([@B17]; [@B11]; [@B62]). Several studies attributed higher morbidity and mortality among patients to medication nonadherence ([@B34]; [@B35]; [@B2]; [@B31]). In addition, nonadherence increases healthcare cost and hospitalization and is associated with deterioration of the quality of life ([@B64]; [@B73]; [@B8]; [@B67]; [@B42]).

Nonadherence is a global issue ([@B14]; [@B74]; [@B46]). A meta-analysis of 20 studies conducted between 1998 and 2010 in Australia, Canada, the USA, and Europe to assess the extent of adherence of cardiovascular patients to their regimens indicated that approximately 50% were not properly adherent to cardiovascular medications prescribed for preventive purposes ([@B59]). However, a meta-analysis of hundreds of studies conducted over a 50-year period reported that, on average, approximately one-fourth of the patients did not adhere to their regimens ([@B19]). Furthermore, a study conducted in Canada in primary healthcare between 2006 and 2009 reported that 31.3% of the written prescriptions were not filled ([@B77]). In 2018, an extensive meta-analysis conducted to measure primary nonadherence to medications of chronic diseases reported a nonadherence rate of 14.6% ([@B53]).

Several factors have been identified to affect patient adherence to prescribed regimens ([@B51]; [@B52]). Those factors include patients' demographic (age and sex) and socioeconomic status (e.g., education, income, and social support) ([@B48]; [@B65]; [@B66]; [@B6]; [@B61]). In addition, patients' cognitive ability, expectations, beliefs, attitude, comorbidities, and poly-pharmacy were reported to be major determinants ([@B81]; [@B58]; [@B24]; [@B68]). Furthermore, factors linked to the healthcare system ([@B43]; [@B29]) and treatment-related issues (side effects and therapy duration) were found to affect levels of adherence ([@B27]).

Some interventions tested globally to enhance adherence included simple dose adjustment and reduction of the number of medications ([@B9]; [@B71]), reminders and improved scheduling ([@B10]), and educational interventions ([@B49]; [@B79]). Other interventions included more comprehensive and complex strategies, such as expansion of the pharmacist role in health care, enhancement of patient--health care provider communication and trust, provision of services ([@B55]; [@B4]), proper description of disease and medications ([@B64]; [@B37]), habit analysis and management of side effects ([@B63]; [@B12]), patient follow-up, social and behavioral support and motivation ([@B20]; [@B80]; [@B49]; [@B24]), and acting on patients' feedback ([@B23]).

Although adherence to medications is crucial for successful treatment strategies, less attention has been given to this issue until recently ([@B76]; [@B40]). The lack of detailed knowledge on the frequency, causes, and consequences of nonadherence obstructs the elaboration of interventions ([@B25]; [@B72]).

Nonadherence in Hungary has so far been little investigated. According to the self-reported data of the European Social Survey ([@B50]), 18% of participants did not adhere precisely to the prescribed regimens in Europe. The nonadherence rate detected in this survey was 20.3% in Hungary. This fourth highest rate among the 24 surveyed countries (with reported rates ranging from 6.3% to 25.2%) suggests that nonadherence is of especially high importance in Hungary ([@B75]). It seems plausible that this relatively high nonadherence rate contributes to the relatively high amenable mortality in Hungary, which is 2.1 times higher than the average in the European Union, according to the EUROSTAT statistics for 2015 (). Since the Hungarian primary health care performance is ranked in the weakest third in Europe ([@B47]), general medical practices may be a potential target of intervention to improve adherence and thereby to improve the public health status in the country. It is worth mentioning that the health insurance in Hungary, provided by the National Health Insurance Fund (NHIF), covers more than 96% of the population. The costs of medicines are shared by the NHIF and the patient by a health insurance scheme. Due to this cost sharing, patients are not motivated to hide any drug consumption from the NHIF ([@B28]). Thus, its data on prescribed and dispensed drugs are reliable and can be used to assess adherence to medications in a nationally representative manner.

The aims of this study were 1) to describe adherence to general practitioner (GP)-prescribed medications among Hungarian adults by quantifying the dispensed proportion of prescribed medications, 2) to describe the variability of this adherence across general medical practices, and 3) to assess the influence of general medical practices' structure and patients' characteristics on that variability. For this study, we hypothesized that nonadherence to GP-prescribed medications among adults in Hungary is related to patients' characteristics (age, sex, eligibility for exemption certificate) and general medical practice characteristics such as socioeconomic status of adults provided (indicated by standardized relative education), list size of general medical practice, GP vacancy, type of settlement, and location by county where general medical practice is located.

Methods {#s2}
=======

Setting {#s2_1}
-------

This study was a secondary database analysis. The unit of analysis was the prescription written by a GP and dispensed by patients. Data on written and dispensed prescriptions were obtained from the NHIF. All general medical practices (GMPs) operating in Hungary were investigated. The available data covered the period from the beginning of 2012 until the end of the third quarter of 2015.

Data {#s2_2}
----

These data were stratified by age (5-year bands), sex, and possession of exemption certificate. Drugs were classified according to the Anatomical Therapeutic Chemical (ATC) Classification recommended by the WHO ([@B82]). ATC groups of "Antineoplastic and immunomodulating agents" and "Antiparasitic products, insecticides, and repellents" were not included in the analyses because the use of these drugs is not connected to GPs according to the Hungarian regulations.

The NHIF also provided data on the characteristics of GMPs. GMPs were described by the number of adults for which care was provided using the official categorization of the NHIF (less than 800, 801--1,200, 1,201--1,600, 1,601--2,000, and 2,001 or more patients). GMPs were also categorized as having a vacant or filled GP position (provided by a temporary GP with availability restricted in time and place or by a permanent contracted GP with continuous availability). Rural or urban GMPs were distinguished. GMPs were classified according to their geographical location by county.

The socioeconomic status of the adults receiving care at each GMP was approximated by the sex- and age-internally standardized relative education. This indicator was computed by indirect method, using sex and age group-specific levels of education from the 2011 Hungarian Census and the sex and age group composition of GMP clients ([@B39]). Since internal standardization was applied, the national average of socioeconomic status corresponds to value 1 of standardized relative education.

Statistical Analysis {#s2_3}
--------------------

The sex-, age-, and exemption certificate-specific number of written and dispensed prescriptions and the percentage of drugs actually dispensed (dispensed to written ratio, DWR) as the indicator for medication adherence ([@B83]) were determined by the NHIF for the whole country for the investigated period. These national reference DWRs were calculated for each studied ATC group. NHIF data on prescribed and dispensed drugs are reliable and the statistical power could be ensured by the applied design being strong.

Our dependent variables were adherence ratios indirectly standardized for age, sex, and exemption certificate. These standardized adherence ratios were calculated by dividing the agregated GMP-specific numbers of the observed dispensed prescriptions by the aggregated GMP-specific numbers of expected dispensed prescriptions.

Using the sex-, age-, and exemption certificate-specific number of written prescriptions by GMP and the national reference DWRs, the expected number of dispensed prescriptions was calculated for each GMP (summarizing the expected number of dispensed prescriptions across strata). The ratio of the registered number of filled prescriptions in a GMP and the calculated GMP-specific expected number of dispensed prescriptions was computed as the GMP-specific standardized DWR (SDWR) for each ATC group.

The distributions of the ATC group-specific and the general SDWR values computed for GMP were not normal according to Kolmogorov--Smirnov testing ([**Supplementary Appendix 14**](#SM1){ref-type="supplementary-material"}). Median values and interquartile ranges were used to describe their distribution. Taking into consideration that calculated SDWRs were positive numbers, Box--Cox transformation was applied to normalize the SDWRs ([@B15]) (histograms for original and transformed SDWR parameters are in [**Supplementary Appendix 15**](#SM1){ref-type="supplementary-material"}).

To identify the factors that influence the SDWR by controlling for the time, we conducted generalized linear modeling. Linear regression coefficients (*b*) with the corresponding 95% confidence interval (95%CI) were calculated. In the model, GP vacancy and settlement type were used as binary parameters, and county location and GMP size were used as dummy variables with reference categories of Budapest and GMP size of 1,601--2,000 persons, respectively. This analysis was also conducted for each ATC group. Pearson's chi-square goodness-of-fit test was applied to describe the performance of regression modeling.

The level of significance was fixed at 95% (*p* \< 0.05). SPSS version 20 was used in the data analysis.

Results {#s3}
=======

The distribution of characteristics for the 4,856 GMPs investigated is summarized in [**Table 1**](#T1){ref-type="table"}. Of the studied GMPs, 3.30% were vacant, and 34.70% were in rural areas. The majority of GMPs provided care to 1,201--1,600 (30.5%) or 1,601--2,000 (31.7%) adults. Due to the internal approach of indirect standardization, the mean relative education of the provided population was 1.00 (SD ± 0.10).

###### 

Distribution of general medical practice (GMP) characteristics in Hungary.

  Variable name                     Number of GMP (%)        
  --------------------------------- ------------------------ ---------------
  Vacancy of general practitioner   Vacant                   160 (3.3)
                                    Fulfilled                4,696 (96.7)
  Type of settlement                Rural                    1,683 (34.7)
                                    Urban                    3,173 (65.3)
  Size of GMP                       \<800                    158 (3.3)
                                    800--1,200               677 (13.9)
                                    1,201--1,600             1,481 (30.5)
                                    1,601--2,000             1,541 (31.7)
                                    \> 2,000                 999 (20.6)
  County                            Budapest                 875 (18)
                                    Baranya                  209 (4.3)
                                    Bács-Kiskun              256 (5.3)
                                    Békés                    191 (3.9)
                                    Borsod-Abaúj-Zemplén     377 (7.8)
                                    Csongrád                 205 (4.2)
                                    Fejér                    196 (4)
                                    Gyo˝r                    205 (4.2)
                                    Hajdú-Bihar              246 (5.1)
                                    Heves                    161 (3.3)
                                    Komárom-Esztergom        146 (3)
                                    Nógrád                   109 (2.2)
                                    Pest                     477 (9.8)
                                    Somogy                   177 (3.6)
                                    Szabolcs-Szatmár-Bereg   267 (5.5)
                                    Jász-Nagykun-Szolnok     194 (4)
                                    Tolna                    121 (2.5)
                                    Vas                      134 (2.8)
                                    Veszprém                 169 (3.5)
                                    Zala                     141 (2.9)
  Total number of GMPs                                       4,856 (100.0)

In general, the observed DWR was 64.1% ([**Table 2**](#T2){ref-type="table"}). There was only a slight difference between men (63.6%) and women (64.5%). Age showed considerable influence. The lowest DWR was registered for middle-aged adults (62.1%). The highest was detected among adults with exemption certificates (78.3%). Regarding sex and exemption certificate, the same pattern was observed for each ATC group, while the age dependency of the DWR varied by ATC group (details in [**Supplementary Appendices 1--12**](#SM1){ref-type="supplementary-material"}).

###### 

Dispensed to written prescription ratio by patient characteristics in Hungary in the period from 1 January 2012 to 30 September 2015.

  Patient characteristics   Written prescriptions   Dispensed prescriptions   Percentage of the dispensed prescriptions   
  ------------------------- ----------------------- ------------------------- ------------------------------------------- ------
  Age groups (years)        18--44                  39,971,036                25,539,871                                  63.9
                            45--64                  171,996,562               106,753,470                                 62.1
                            65 and above            226,646,402               149,022,045                                 65.8
  Sex                       Male                    172,358,931               109,603,855                                 63.6
                            Female                  266,255,069               171,711,531                                 64.5
  Exemption certificate     Yes                     47,960,440                37,548,944                                  78.3
                            No                      390,653,560               243,766,442                                 62.4
  Total                     438,614,000             281,315,386               64.1                                        

There was wide variability of the DWR by drug class ([**Table 3**](#T3){ref-type="table"}). The lowest DWR was registered for cardiovascular system drugs at 59.4%. The highest value was 79.1%, reported for the anti-infective drugs for systemic use.

###### 

Dispensed to written prescription ratio by ATC group in Hungary in the period from 1 January 2012 to 30 September 2015.

                                          Written prescriptions   Dispensed prescriptions   Percentage of the dispensed prescriptions
  --------------------------------------- ----------------------- ------------------------- -------------------------------------------
  Alimentary tract and metabolism         71,736,340              49,208,724                68.6
  Blood and blood forming organs          30,237,857              20,921,060                69.2
  Cardiovascular system                   228,225,210             135,489,086               59.4
  Dermatologicals                         4,382,185               2,707,111                 61.8
  Genitourinary system and sex hormones   3,396,924               2,289,588                 67.4
  Systemic hormonal preparations\*        4,822,082               3,570,757                 74.1
  Antiinfectives for systemic use         13,348,380              10,559,995                79.1
  Musculoskeletal system                  29,820,787              20,541,099                68.9
  Nervous system                          28,337,910              20,040,657                70.7
  Respiratory system                      21,830,141              14,357,120                65.8
  Sensory organs                          1,626,640               1,113,623                 68.5
  Various                                 849,544                 516,566                   60.8
  Altogether\^                            438,614,000             281,315,386               64.1

\*Excluding sex hormones and insulin.

\^ATC groups of "Antineoplastic and immunomodulating agents" and "Antiparasitic products, insecticides, and repellents" were not studied.

The SDWRs varied over a wide range. The limits of the interquartile range were 0.87 and 1.22. The interquartile ranges for the ATC groups varied between 0.14 (anti-infectives for systemic use) and 0.42 (cardiovascular system agents) apart from the various (ATC V) groups ([**Supplementary Appendix 13**](#SM1){ref-type="supplementary-material"}).

An inverse association was found between normalized SDWRs (*D* = 0.002; *p* = 0.200 according to the Kolmogorov--Smirnov test as presented in [**Supplementary Appendix 14**](#SM1){ref-type="supplementary-material"}) and the relative education of the adult population that received care (*b* = -0.440, 95%CI = -0.468 to -0.413), vacancy of GP (*b* = -0.193, 95%CI = -0.204 to -0.182), and urban residential place (*b* = -0.099, 95%CI = -0.103 to -0.094). The size of the GMP proved to be a significant influencing factor. A relatively higher SDWR was observed in smaller GMPs (*b* *~X~* ~--800~ = 0.052, 95%CI = 0.041--0.063, *b* ~801--1200~ = 0.031, 95%CI = 0.025--0.037, *b* ~1201--1600~ = 0.017, 95%CI = 0.013--0.022), while the larger GMPs showed a lower SDWR (*b* ~2001--~ *~X~* = -0.014, 95%CI = -0.019 to -0.009).

There was a significant impact of geographical location according to the county-specific regression coefficients ([**Table 4**](#T4){ref-type="table"}). According to the generalized linear regression coefficients, the urban residential place, high relative education, and vacant GP position (in decreasing effect size) are the stronger factors that reduce the GMP-level SDWR. This general pattern was observed for each studied ATC group ([**Supplementary Appendix 16**](#SM1){ref-type="supplementary-material"}).

###### 

Generalized linear modeling\^ on the associations between general medical practice (GMP) characteristics and normalized\* age-, gender-, and exemption certificate-standardized dispensed to written prescription ratios among Hungarian adults in the period from 1 January 2012 to 30 September 2015.

                                                Regression coefficient \[95%CI\]
  --------------------------------------------- ----------------------------------
  Standardized relative education\*\*           --0.440 \[-0.468; -0.413\]
  Vacant GP position/filled GP position         --0.193 \[-0.204; -0.182\]
  Urban/rural                                   --0.099 \[-0.103; -0.094\]
  *X*--800 GMP size/1,601--2,000 GMP size       0.052 \[0.041; 0.063\]
  801--1,200 GMP size/1,601--2,000 GMP size     0.031 \[0.025; 0.037\]
  1,201--1,600 GMP size/1,601--2,000 GMP size   0.017 \[0.013; 0.022\]
  2,001--*X* GMP size/1,601--2,000 GMP size     --0.014 \[-0.019; -0.009\]
  Baranya county/Budapest                       0.083 \[0.072; 0.093\]
  Bács-Kiskun county/Budapest                   0.056 \[0.046; 0.067\]
  Békés county/Budapest                         0.023 \[0.012; 0.033\]
  Borsod-Abaúj-Zemplén county/Budapest          --0.015 \[-0.024; -0.006\]
  Csongrád county/Budapest                      0.021 \[0.011; 0.032\]
  Fejér county/Budapest                         --0.132 \[-0.142; -0.121\]
  Gyo˝r-Moson-Sopron county/Budapest            --0.002 \[-0.012; 0.008\]
  Hajdú-Bihar county/Budapest                   --0.035 \[-0.045; -0.025\]
  Heves county/Budapest                         --0.033 \[-0.044; -0.021\]
  Jász-Nagykun-Szolnok county/Budapest          0.044 \[0.033; 0.055\]
  Komárom-Esztergom county/Budapest             0.072 \[0.060; 0.084\]
  Nógrád county/Budapest                        --0.028 \[-0.042; -0.015\]
  Pest county/Budapest                          --0.002 \[-0.01; 0.006\]
  Somogy county/Budapest                        0.079 \[0.068; 0.09\]
  Szabolcs-Szatmár-Bereg county/Budapest        0.074 \[0.064; 0.084\]
  Tolna county/Budapest                         0.060 \[0.047; 0.073\]
  Vas county/Budapest                           0.103 \[0.091; 0.115\]
  Veszprém county/Budapest                      0.006 \[-0.006; 0.017\]
  Zala county/Budapest                          0.017 \[0.005; 0.029\]

*\*Box--Cox transformation.*

\*\*Standardized continuous parameter.

\^p = 0.060 (Pearson's chi-square goodness-of-fit test).

Discussion {#s4}
==========

Our investigation, which is the first population-based study in Hungary on medication nonadherence, found that only 64.1% of the medicines prescribed by a GP in Hungary are dispensed. This kind of adherence varies from 59.4% (cardiovascular systems' agents) to 79.1% (anti-infectives for systemic use) by ATC groups. This registered nonadherence (35.9%) is higher than the levels of nonadherence observed in Canada (31.3%), Woonsocket, USA (24%), Massachusetts, USA (22.5%), Scotland (14.5%), and Sweden (2.4%) ([@B5]; [@B21]; [@B25]; [@B26]; [@B77]).

Gender has proven to be not an important determinant of nonadherence, while middle-aged adults are at risk of not dispensing prescribed medications. The strong protective role of eligibility for exemption certificates demonstrates the influence of patients' socioeconomic status.

According to our regression models, the urban environment is a risk factor for nonadherence. There are publications with similar ([@B45]) and opposite ([@B65]; [@B41]) conclusions. Certain elements of the urban lifestyle (better access to health services, better economic conditions, special working schedule, and urban attitude and beliefs) supposed to underlie these variable observations ([@B60]; [@B54]; [@B44]; [@B56]; [@B7]) urge further investigations in Hungary as key obstacles to medication adherence.

Our study found a relatively strong negative association between education and the level of adherence. This finding is consistent with findings reported by the second round of the European Social Survey ([@B50]), but there are publications on the positive association between education and medication adherence, as well ([@B41]; [@B16]). A higher level of education can be an indicator of a better ability to perceive the benefit of GPs' instructions ([@B58]). However, the effect of education on adherence is complex ([@B38]), and not only knowledge but also the education-related attitude plays an important role ([@B1]). Highly educated people hold themselves accountable for their own health ([@B32]) and are more critical towards GPs' instructions ([@B30]). Our observation could reflect a poor collaboration between patients and GPs, which counterbalances the better understanding of medications' benefit.

Our study demonstrated the adherence-decreasing role of GP vacancies, when a permanent GP replacing the missing GP provides care. A similar finding was reported in South Korea ([@B65]). This effect can be straightforwardly explained by the well-known importance of the continuity of care and trust in physicians ([@B69]; [@B33]; [@B57]). On the other hand, this result demonstrates that the workforce crisis in primary health care (resulting in increasing number of GP vacancies) exerts its detrimental effect on patients' prognosis ([@B70]) through reduced adherence to medication.

The importance of geographical inequalities in medication adherence ([@B13]; [@B18]) has been confirmed by our results. The county in our context can be considered a summary indicator of many spatially variable factors not related to urbanization, level of education, GP vacancy, or socioeconomic status (controlled by standardization for sex, age, and eligibility for an exemption certificate). The importance of the availability of health services, not controlled for our investigation, may be reflected in this observation ([@B78]). According to our results, this impact is less than the impact of GP vacancy, level of education, and urban living environment.

Our study could demonstrate the importance of the GMP list size: the more patients belong to a GMP, the lower the medication adherence. Taking into consideration that one GP and one nurse represent the typical staff in a Hungarian GMP ([@B28]), this effect may be simply attributed to the less time that can be devoted to a patient.

Implications {#s4_1}
------------

The observed high medication nonadherence obviously contributes to the impaired prognosis of diseases that can be treated by medications available. Although this impact could not be quantified in this investigation, taking into consideration the 59.4% observed adherence for cardiovascular diseases (which basically determines the life expectancy in European countries), this impact can be great, requiring further and more detailed studies and likely urging interventions.

On the other hand, the work, time, and capacities behind a prescription not filled contribute to the waste of resources in health care. Therefore, the observed nonadherence can also be considered an indicator of the effectiveness of patient--GP cooperation. The wide variability in GMP-level adherence we observed suggests that primary health care (PHC) teams have variable effectiveness in this respect. Furthermore, our results demonstrate that the role of GPs is especially weak in managing patients' diseases among urban and higher educated adults. Consequently, the PHC monitoring system needs to be completed with primary medication adherence monitoring to identify GMPs to be improved and to benchmark the necessary interventions including, *inter alia*, educational interventions and improving patient physician relationship and communication.

Strengths and Limitations {#s5}
=========================

The health insurance in Hungary, provided by the NHIF, covers more than 96% of the population. The costs of medicines are shared by the NHIF and the patient by a health insurance scheme. Due to this cost sharing, patients are not motivated to hide any drug consumption from the NHIF ([@B28]). Thus, its data on prescribed and dispensed drugs are reliable and can be used to assess adherence to medications in a nationally representative manner. The statistical power could be ensured by the applied design being strong.

Although drug dispensing estimation is an objective process and is considered the most reliable method for assessing adherence in integrated healthcare systems, this approach cannot address other aspects of adherence (drug application according to the prescribed regime). In fact, our study gives an idea of patient's initial decision to remain on prescribed medications. Furthermore, many important factors that can influence adherence, such as side effects, comorbidity and polypharmacy, access to healthcare, and patient attitudes, were not available through the analyzed database and were not included in our study model, which restricts the convincing power of the observed associations, obviously. Further research with more explanatory parameters is required to improve the relevance of our findings. Finally, our observations need confirmation by studies with individual-level data on patient characteristics.

Conclusions {#s6}
===========

More than one-third of the written prescriptions of GPs for adults were not dispensed in Hungary. This high level of nonadherence was realized with a wide variability across GMPs can be explained by structural characteristics of GMPs, the socioeconomic status of patients provided, and the quality of cooperation between patients and GPs. Moreover, our findings suggest that the use of the dispensed-to-prescribed medication ratio in routine monitoring of primary health care can effectively support the necessary interventions. Since we have determined an alarmingly high level of nonadherence across the country, and given that nonadherence has a multifactorial etiology, our study urges further investigations to determine the main obstacles to primary nonadherence.
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